3-Methyl-4-oxo-3,4-dihydro-pyrazolo[5,1-d][1,2,3,5]tetrazine-8-carboxylic acid amide

ID: ALA287366

PubChem CID: 13282219

Max Phase: Preclinical

Molecular Formula: C6H6N6O2

Molecular Weight: 194.15

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  Cn1nnc2c(C(N)=O)cnn2c1=O

Standard InChI:  InChI=1S/C6H6N6O2/c1-11-6(14)12-5(9-10-11)3(2-8-12)4(7)13/h2H,1H3,(H2,7,13)

Standard InChI Key:  NHXAXFAKTMZCOV-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 14 15  0  0  0  0  0  0  0  0999 V2000
    6.2625   -7.2000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.2542   -6.3750    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9667   -7.6042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9667   -5.9542    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.4667   -6.1167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.6792   -6.3750    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.6792   -7.2000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.4792   -7.4542    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.9875   -6.7917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2125   -5.3375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9667   -8.4292    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.7542   -4.7250    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.4042   -5.1667    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.4000   -7.6125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  3  1  1  0
  4  2  1  0
  5  2  2  0
  6  7  1  0
  7  3  1  0
  8  1  1  0
  9  8  2  0
 10  5  1  0
 11  3  2  0
 12 10  2  0
 13 10  1  0
 14  7  1  0
  5  9  1  0
  6  4  2  0
M  END

Associated Targets(Human)

GM892A cell line (10 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Raji (5516 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

L1210 (27553 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Biocomponents

Calculated Properties

Molecular Weight: 194.15Molecular Weight (Monoisotopic): 194.0552AlogP: -2.08#Rotatable Bonds: 1
Polar Surface Area: 108.17Molecular Species: NEUTRALHBA: 7HBD: 1
#RO5 Violations: HBA (Lipinski): 8HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 11.01CX Basic pKa: CX LogP: -0.25CX LogD: -0.25
Aromatic Rings: 2Heavy Atoms: 14QED Weighted: 0.56Np Likeness Score: -1.90

References

1. Clark AS, Deans B, Stevens MF, Tisdale MJ, Wheelhouse RT, Denny BJ, Hartley JA..  (1995)  Antitumor imidazotetrazines. 32. Synthesis of novel imidazotetrazinones and related bicyclic heterocycles to probe the mode of action of the antitumor drug temozolomide.,  38  (9): [PMID:7739008] [10.1021/jm00009a010]
2. Cheng CC, Elslager EF, Werbel LM, Priebe SR, Leopold WR..  (1986)  Pyrazole derivatives. 5. Synthesis and antineoplastic activity of 3-(2-chloroethyl)-3,4-dihydro-4-oxopyrazolo[5,1-d]-1,2,3, 5-tetrazine-8-carboxamide and related compounds.,  29  (8): [PMID:3735323] [10.1021/jm00158a041]

Source